Literature DB >> 6223411

Natural and antibody-dependent cellular cytotoxicity of polymorphonuclear leukocytes.

M Ohara, M Shirado, M Miyata, H Sakuma, M Nanamiya, N Yoshida, H Yoshida, R Kasukawa.   

Abstract

Cytotoxic activity of polymorphonuclear leukocytes (PMN) in the peripheral blood of patients with various diseases was demonstrated to K562 cells (natural cytotoxicity, NC) and the antibody-coated P815 cells (antibody-dependent cellular cytotoxicity, ADCC), using a 51Cr-release method. The NC values of normal PMN were lower than those of normal lymphocytes with mean values of 5.0% and 30%, respectively. The NC values of patients' PMN were also lower in malignancy, chronic hepatitis and connective tissue diseases. The ADCC values of normal PMN were moderately high with a mean value of 16.0%, which was almost a half of normal lymphocytes. Higher ADCC values of PMN were found in patients with chronic hepatitis, SLE and Behcet's disease, and in these cases the ADCC values of their lymphocytes were extremely low. The supernatants of PMN mix-cultured with unlabeled K562 or the antibody-coated P815 cells were fairly cytotoxic to both cells, though the similar supernatants of lymphocytes were cytotoxic only to K562 cells, but not to the antibody-coated P815 cells.

Entities:  

Mesh:

Year:  1983        PMID: 6223411     DOI: 10.1620/tjem.140.59

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  Phospholipid base exchange activity in the leukocyte membranes of patients with inflammatory disorders.

Authors:  Y Niwa; T Sakane; Y Ozaki; T Kanoh; S Taniguchi
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

2.  Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus.

Authors:  Celene M O S Alves; Cleni M Marzocchi-Machado; Paulo Louzada-Junior; Ana Elisa C S Azzolini; Ana Cristina M Polizello; Ivan F de Carvalho; Yara M Lucisano-Valim
Journal:  Clin Rheumatol       Date:  2007-10-23       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.